Qnity Q3 sales rise 22%, guidance raised; valuation still leaves no margin of safety

What happened

Qnity Electronics reported third-quarter sales growth of 22%, driven by demand for advanced semiconductor materials and AI-related products, and raised its full-year 2026 outlook. This follows the company's earlier Q1 results, which had already prompted management to raise FY2026 guidance to net sales of $5.225B–$5.375B and adjusted EBITDA of $1.535B–$1.625B, and the Q3 update suggests further upward revision. The market narrative remains focused on Qnity's role in AI infrastructure and advanced packaging, but the stock trades at roughly 26x EV/EBITDA and 50x earnings, leaving little room for execution missteps. Filings flag that customer inventory cycles can distort demand, and Asia Pacific accounts for the majority of sales, so sustained growth hinges on end-demand rather than buffer builds. Additionally, the company carries $4 billion in debt with a variable-rate term loan, making earnings sensitive to interest rates, and transformation and separation costs are still being absorbed.

Implication

The Q3 beat and raised guidance confirm near-term demand strength, but the master report's key risk factors remain: high valuation, leverage, and inventory cycle sensitivity. The next checkpoint is whether Asia sales show sequential growth and whether FY2026 free cash flow is tracking toward the raised guidance, as that would validate the operating model. Any signs of customer destocking or weakening in Asia would trigger a reassessment, as the stock's premium multiple leaves little tolerance for disappointment. Transformation charges and interest expense should be monitored for any increase that could offset the revenue gains. Until there's clearer evidence that advanced packaging qualifications convert to volume awards, the risk-reward remains unattractive at current prices; consider buying near $135 or waiting for a pullback.

Thesis delta

The Q3 results reinforce our base-case demand assumptions but do not change our WAIT rating. The raised outlook supports our base scenario, but the valuation remains steep and risks around inventory timing and cash conversion persist. We maintain our attractive entry at $135 and see no margin of safety at current levels.